EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023

Il-Hwan Kim, Jin Sun No, Jeong-Ah Kim, Ae Kyung Park, HyeokJin Lee, Jeong-Min Kim, Nam-Joo Lee, Chi-Kyeong Kim, Chae Young Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee und 1 weitere

Virology · 2023

DOI: 10.1016/j.virol.2023.109869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virology, 2023. Verfasst von Il-Hwan Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Sout…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Disease Control and Prevention Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Korea Disease Control and Prevention Agency (KDCA) has been conducting national genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). To monitor and characterize circulating SARS-CoV-2 variants in South Korea, 102,873 oropharyngeal/nasopharyngeal swab samples collected from patients with confirmed COVID-19 were sequenced, assigned lineages, and phylogenetically analyzed. Each wave followed a pattern of variants emerging first abroad and then spreading domestically. In 2020, B.41 lineage led the first wave, and B.1.497 dominated the second and third waves. In 2021, the fourth wave was driven by Delta (AY.69 and AY.122.5). In 2022, the fifth to seventh waves were dominated by Omicron sub-lineages BA.1/BA.1.1 and BA.2/BA.2.3, BA.5/BA.5.2, and BN.1, sequentially. The KDCA detected and monitored increasing variants in advance prior to large-scale epidemics, but the repeated emergence of new variants could threaten public health again. Therefore, it is important to continue to monitor and characterize emerging and circulating variants through national genomic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansRepublic of KoreaPhylogenyGenome, ViralMolecular EpidemiologyGenomicsMiddle AgedAdultMaleFemale

Stichwörter der Autor:innen

COVID-19Genomic epidemiologyGenomic surveillancePhylogenetic analysisSARS-CoV-2Variant

Autor:innen und Institutionen

  • Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, South Korea.
  • Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, South Korea. Electronic address: ekim@korea.kr.

Förderung

  • Korea Disease Control and Prevention Agency

Zitieren

APA

Kim, I. H., No, J. S., Kim, J. A., Park, A. K., Lee, H., Kim, J. M., Lee, N. J., Kim, C. K., Lee, C. Y., Woo, S., Lee, J., Rhee, J., & Kim, E. J. (2023). Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023. Virology. https://doi.org/10.1016/j.virol.2023.109869

Vancouver

Kim IH, No JS, Kim JA, Park AK, Lee H, Kim JM, et al. Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023. Virology. 2023. doi:10.1016/j.virol.2023.109869

BibTeX
@article{Kim2023,
  author = {Kim, Il-Hwan and No, Jin Sun and Kim, Jeong-Ah and Park, Ae Kyung and Lee, HyeokJin and Kim, Jeong-Min and Lee, Nam-Joo and Kim, Chi-Kyeong and Lee, Chae Young and Woo, SangHee and Lee, Jaehee and Rhee, JeeEun and Kim, Eun-Jin},
  title = {Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023},
  journal = {Virology},
  year = {2023},
  doi = {10.1016/j.virol.2023.109869}
}
Kostenlos starten →